Compare RGR & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGR | USNA |
|---|---|---|
| Founded | 1949 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.9M | 371.5M |
| IPO Year | N/A | 1996 |
| Metric | RGR | USNA |
|---|---|---|
| Price | $32.67 | $19.55 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | ★ 458.4K | 139.1K |
| Earning Date | 02-18-2026 | 10-22-2025 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.16 | ★ 0.90 |
| Revenue | $540,770,000.00 | ★ $912,670,000.00 |
| Revenue This Year | $0.73 | $9.80 |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | $206.33 | ★ $21.84 |
| Revenue Growth | 3.90 | ★ 5.88 |
| 52 Week Low | $28.33 | $18.48 |
| 52 Week High | $48.21 | $38.32 |
| Indicator | RGR | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 42.81 |
| Support Level | $32.05 | $19.44 |
| Resistance Level | $32.89 | $19.98 |
| Average True Range (ATR) | 0.93 | 0.51 |
| MACD | 0.27 | -0.02 |
| Stochastic Oscillator | 56.99 | 7.00 |
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.